20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have ...

Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...

NTx’s new services offering provides faster and more affordable high-integrity, complex mRNA production powered by NTxscribe® ...

We recently compiled a list of the Jim Cramer’s Top 12 Must-Watch Stocks. In this article, we are going to take a look at ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the ...

Jim Cramer’s 10 Best Stock Picks for Investors Right Now. In this article, we are going to take a look at where Moderna, Inc.

Canaccord Genuity analyst Whitney Ijem maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report) yesterday and set a ...

Fintel reports that on September 13, 2024, Jefferies downgraded their outlook for Moderna (NasdaqGS:MRNA) from Buy to Hold.

WestGene Biopharma, a leading innovator in mRNA therapeutics, presented the latest clinical data for its EBV-positive tumour ...

Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients ...

Fintel reports that on September 13, 2024, JP Morgan downgraded their outlook for Moderna (NasdaqGS:MRNA) from Neutral to ...